<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01539304</url>
  </required_header>
  <id_info>
    <org_study_id>CITUS_P3</org_study_id>
    <nct_id>NCT01539304</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Evaluate the Safety and Efficacy of &quot;CITUS Dry Syrup&quot; in Children With Perennial Allergic Rhinitis</brief_title>
  <official_title>Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of &quot;CITUS Dry Syrup&quot; in Children With Perennial Allergic Rhinitis: Double Blinded, Randomized, Placebo Controlled, Parallel Designed, Multi-centered, Phase III Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SamA Pharmaceutical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SamA Pharmaceutical Co., Ltd</source>
  <brief_summary>
    <textblock>
      Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of &quot;CITUS Dry
      Syrup&quot; in Children With Perennial Allergic Rhinitis: Double Blinded, Randomized, Placebo
      Controlled, Parallel Designed, Multi-centered, Phase III Study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change from baseline in NIS(Nasal Index Score) over the 4-week treatment period</measure>
    <time_frame>4 week treatment period (from baseline through the end of week 4)</time_frame>
    <description>Evaluation : from baseline(1-week prior to treatment)over the 4-week treatment(1-week prior to patients' last visit).
NIS : Sum of 4 individual scores for Nasal congestion, Rhinorrhea, Sneezing, and Nasal itching, each rated by patients daily on a 4-point scale [Score 0(best) to 3(worst)].</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing improvement of symptom by physician</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing improvement of symptom by patient</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change of Individual NIS</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio distribution of NIS at end of week 4</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
    <description>Percentage of each NIS score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cure rate</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cure rate for each symptom</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue medication</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Instantaneous NIS</measure>
    <time_frame>from baseline through the end of week 4</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">245</enrollment>
  <condition>Perennial Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>CITUS Dry Syrup</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pranlukast dry syrup 10%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CITUS Dry Syrup</intervention_name>
    <description>Pranlukast 10% dry syrup, b.i.d.</description>
    <arm_group_label>CITUS Dry Syrup</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo dry syrup, b.i.d</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children aged over 24 months and under 15 years.

          2. Patients who was diagnosed with perennial allergic rhinitis by ImmunoCAP test.

          3. NIS mean total score of 1-week in baseline should be over 4.0.

        Exclusion Criteria:

          1. Patient who is accompanied by the seriously abnormal symptom in respiratory system,
             such as pneumonia, cystic fibrosis, viral influenza, tuberculosis, asthma(status
             praesens).

          2. Patient who has cancer, diabetes mellitus, hypertension, CNS disease, and metabolic
             disease which need medication.

          3. Patient who has rhinitis not caused by allergy.

          4. Acute or chronic sinusitis.

          5. Patient who has medical history of allergy in seasonal pollen during the trial.

          6. Patient who has had eyes or nose surgery within 3 months prior to the trial.

          7. Patient who has had eye or upper airway infection within 1 week prior to the treatment
             period.

          8. Beginning immunotherapy or dose of change within 1 month prior to the trial.

          9. Patient who has clinical history of sensitivity to allergic rhinitis medication.

         10. Patient whose heart function is abnormal: including heart failure, abnormal ECG test
             value that is clinically significant.

         11. Patient who has experience to have participated in other clinical trial within 2
             months prior to the trial.

         12. Patient who has taken contraindicated medications in this study within 1 week(baseline
             period) prior to the treatment period.

         13. For girl who had her first period, result of pregnancy test was positive.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Months</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Yull Koh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bok Yang Pyun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jae Won Oh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yeong Ho Na, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyunghee University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soo Jong Hong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyun Hee Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea Bucheon St.Mary's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dae Hyun Lim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kang Mo Ahn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myung Hyun Sohn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Tack Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea, Uijeongbu ST. Mary's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hodpital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2012</study_first_submitted>
  <study_first_submitted_qc>February 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2012</study_first_posted>
  <last_update_submitted>February 26, 2012</last_update_submitted>
  <last_update_submitted_qc>February 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

